The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.70 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3Q2019 Results

12 Nov 2019 07:34

RNS Number : 0863T
EFG-Hermes Holdings SAE
12 November 2019
 

http://www.rns-pdf.londonstockexchange.com/rns/0863T_1-2019-11-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/0863T_2-2019-11-12.pdf

EFG HERMES REPORTS THIRD QUARTER 2019

GROUP EARNINGS OF EGP358 MILLION; ON OPERATING REVENUE OF EGP1.2 BILLION

Cairo, November 12th, 2019 - EFG Hermes reports third quarter 2019, with Group Earnings of EGP358 million on operating revenues of EGP1.2 billion. The Group Total assets stood at EGP39.6 billion at the end of 3Q19.

Key Highlights

 

3Q2019

 

 

·; EFG Hermes posted another solid set of results reflecting its strong and diversified operations, with its Group revenues adding another 25% Y-o-Y to reach EGP1.2 billion in 3Q19; as both its Investment Bank and its NBFIs platforms reported strong Y-o-Y growth;

·; Fees and commissions, which represents 74% of the Group revenues, rose 13% Y-o-Y to EGP872 million, on the back of higher Brokerage and Tanmeyah's revenues;

·; The NBFIs platform continues to deliver strong results, with its revenues climbing 41% Y-o-Y to EGP299 million in 3Q19; underpinned by Tanmeyah's robust revenue growth, with its revenues rising 52% Y-o-Y to EGP252 million in 3Q19;

·; Sell-side revenues gained 11% to reach EGP490 million in 3Q19, on higher Brokerage revenues generated from Egypt, KSA and Structured Products, and despite lower Investment Banking revenues as the comparable 3Q18 was very strong;

·; Buy-side revenues declined 29% Y-o-Y to EGP84 million in 3Q19, on lower management fees booked by FIM. Meanwhile, Private Equity revenues came flat Y-o-Y in 3Q19;

·; Capital markets & treasury operations revenue contribution to the Group's total revenues came at 26% in 3Q19, with its revenues increasing 79% Y-o-Y to EGP302 million. Revenues were supported by net interest earned and realized capital gains;

·; Group operating expenses rose 20% to EGP721 million in 3Q19, mainly on the back of higher operating expenses related to Tanmeyah as its operations expanded Y-o-Y, and on higher variable expenses that increase in line with the increase in revenues. Moreover, the Investment Bank other operating expenses were broadly flat Y-o-Y;

·; The Group net operating profit and the net profit after tax and minority interest climbed 34% Y-o-Y to EGP453 million and EGP358 million, respectively; as the increase in revenues outweighed the increase in expenses.

 

For full report and financial statements, please click on the links on top of the page.

 

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Group Head of IR, Budgeting and Reporting

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTLIFFDLLLFLIA
Date   Source Headline
13th Nov 20088:20 amRNS3rd Quarter Results
3rd Nov 20087:30 amRNSDiscontinuation of combination talks
3rd Nov 20087:00 amRNSDiscussions Discontinued
24th Oct 20083:47 pmRNSSecond Price Monitoring Extn
24th Oct 20083:40 pmRNSPrice Monitoring Extension
23rd Oct 200810:04 amRNSIntention to buy Treasury Shares
1st Oct 20083:46 pmRNSSecond Price Monitoring Extn
1st Oct 20083:40 pmRNSPrice Monitoring Extension
25th Sep 20089:38 amRNSTreasury Stock
18th Aug 20087:05 amRNSInvestment in Panmure Gordon
18th Aug 20087:00 amRNSStrategic Partnership
14th Aug 20088:30 amRNSInterim Results
19th May 20088:15 amRNS1st Quarter Results
14th May 200812:50 pmRNSNotice of Results
24th Apr 20082:47 pmRNSResult of Meeting
24th Apr 20081:03 pmRNSResult of EGM
14th Apr 20089:23 amRNSAcquisition
18th Mar 20088:59 amRNSTalks with Bank Audi SAL
18th Mar 20087:00 amRNSCombination discussions
27th Feb 200810:00 amRNSAnnual Report and Accounts
26th Feb 20088:15 amRNSNotice of Results
7th Jan 20083:45 pmRNSSecond Price Monitoring Extn
7th Jan 20083:40 pmRNSPrice Monitoring Extension
13th Dec 200710:33 amRNSLicense Granted
19th Nov 200712:14 pmRNSHolding(s) in Company
14th Nov 20075:54 pmRNSEFG-Hermes 9M07 Earnings
14th Aug 20075:30 pmRNSSecond Quarter 2007 Earnings
23rd May 20079:37 amRNSRe Joint Venture
21st May 20077:00 amRNSHolding(s) in Company
15th May 20075:55 pmRNS1st Quarter Results
27th Mar 20071:17 pmRNSResult of AGM
12th Mar 20077:00 amRNSStatement re EFG-Hermes KSA
22nd Feb 20077:02 amRNSFinal Results
19th Feb 20077:41 amRNSNotice of Results
19th Feb 20077:00 amRNSDirectorate Change
8th Feb 200711:01 amRNSLicense Awarded
22nd Jan 200712:59 pmRNSHolding(s) in Company
15th Nov 20068:00 amRNS3rd Quarter Results
11th Oct 200612:56 pmRNSResult of Meeting
2nd Oct 20063:48 pmRNSRe OnlineTrading License
4th Sep 20067:00 amRNSResult of Meeting
4th Sep 20067:00 amRNSResult of EGM
15th Aug 20065:31 pmRNSInterim Results
31st Jul 20064:20 pmRNSDirectorate Change
31st Jul 20067:00 amRNSStatement re Abraaj Capital
24th Jul 20062:08 pmRNSStmt re Abraaj Cap. Ltd-Amend
24th Jul 200611:01 amRNSStatement re Abraaj Capital
16th May 20067:00 amRNSInvestment Banking License
15th May 20064:30 pmRNSIssue of Equity
9th May 20061:41 pmRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.